Guangjun Nie Selected Research

Guangjun Nie Research Topics

Disease

115	Neoplasms (Cancer) 12/2022 - 01/2002
16	Neoplasm Metastasis (Metastasis) 03/2022 - 12/2014
14	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2014
13	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 04/2015
6	Melanoma (Melanoma, Malignant) 05/2022 - 09/2012
5	Iron Overload 03/2022 - 01/2015
4	Infarction (Infarctions) 07/2021 - 10/2018
4	Thrombosis (Thrombus) 01/2020 - 01/2018
4	Inflammation (Inflammations) 12/2019 - 07/2013
4	Fibrosis (Cirrhosis) 12/2019 - 10/2013
4	Parkinson Disease (Parkinson's Disease) 01/2018 - 01/2002
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2016
3	Adenocarcinoma 01/2021 - 01/2018
3	Hypoxia (Hypoxemia) 01/2021 - 01/2019
3	Iron Deficiencies 03/2020 - 03/2005
3	Infections 05/2019 - 01/2014
3	Necrosis 01/2019 - 01/2018
3	Alzheimer Disease (Alzheimer's Disease) 08/2017 - 01/2011
3	Triple Negative Breast Neoplasms 01/2017 - 02/2015
2	Colonic Neoplasms (Colon Cancer) 05/2022 - 01/2019
2	Splenomegaly 12/2020 - 10/2020
2	Lymphadenopathy 12/2020 - 10/2020
2	Starvation 11/2020 - 10/2006
2	Hemorrhage 01/2020 - 01/2019

Drug/Important Bio-Agent (IBA)

38	Pharmaceutical PreparationsIBA 07/2022 - 10/2010
24	Peptides (Polypeptides)IBA 01/2021 - 01/2011
19	Proteins (Proteins, Gene)FDA Link 12/2022 - 01/2012
16	IronIBA 03/2022 - 10/2006
9	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2022 - 11/2011
9	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 01/2018
9	VaccinesIBA 01/2022 - 09/2012
8	Gemcitabine FDA Link 01/2022 - 04/2015
8	Small Interfering RNA (siRNA)IBA 01/2022 - 02/2015
8	AntigensIBA 01/2022 - 02/2019
8	GoldIBA 12/2019 - 04/2013
8	Ferritins (Ferritin)IBA 10/2019 - 03/2005
7	Liposomes (Liposome)IBA 11/2021 - 02/2016
6	Transferrin Receptors (Transferrin Receptor)IBA 03/2022 - 03/2005
6	PolymersIBA 01/2022 - 10/2010
5	LipidsIBA 01/2022 - 04/2015
5	Thromboplastin (Tissue Factor)IBA 07/2021 - 09/2015
5	Biological ProductsIBA 01/2021 - 10/2012
5	Silicon Dioxide (Silica)FDA LinkGeneric 01/2021 - 07/2014
5	Thrombin FDA Link 01/2020 - 01/2018
5	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 10/2012
5	HepcidinsIBA 04/2017 - 07/2014
4	Chelating AgentsIBA 03/2022 - 12/2018
4	Angiogenesis InhibitorsIBA 01/2022 - 01/2019
4	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 02/2019
4	RNA (Ribonucleic Acid)IBA 10/2021 - 03/2005
4	A-Form DNA (A-DNA)IBA 03/2021 - 01/2018
4	Fibronectins (Fibronectin)IBA 01/2021 - 01/2019
4	CytokinesIBA 01/2021 - 12/2018
4	Glutathione (Reduced Glutathione)IBA 01/2020 - 06/2018
4	cysteinyl-arginyl-glutamyl-lysyl-alanylIBA 01/2020 - 01/2017
3	pHLIP proteinIBA 12/2022 - 02/2018
3	Messenger RNA (mRNA)IBA 05/2022 - 01/2018
3	LigandsIBA 03/2022 - 02/2014
3	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
3	NanovaccinesIBA 10/2021 - 01/2021
3	Cancer VaccinesIBA 05/2021 - 09/2012
3	Therapeutic UsesIBA 01/2021 - 12/2015
3	PlatinumIBA 01/2020 - 06/2018
3	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 01/2018
3	FibrinIBA 01/2020 - 01/2019
3	AntioxidantsIBA 06/2018 - 01/2002
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 12/2014
3	Amyloid (Amyloid Fibrils)IBA 08/2017 - 01/2011
3	Oxidopamine (6 Hydroxydopamine)IBA 09/2010 - 01/2002
2	ThioredoxinsIBA 12/2022 - 02/2018
2	mRNA VaccinesIBA 05/2022 - 10/2021
2	graphene oxideIBA 10/2021 - 12/2014
2	HydrogelsIBA 10/2021 - 02/2018
2	NucleolinIBA 07/2021 - 01/2018
2	polydopamineIBA 01/2021 - 01/2017
2	Beclin-1IBA 10/2020 - 02/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020 - 06/2018
2	IonsIBA 08/2020 - 01/2020
2	Deferoxamine (Desferal)FDA LinkGeneric 01/2020 - 01/2019
2	MetalsIBA 01/2020 - 12/2005
2	SolutionsIBA 01/2020 - 04/2019
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2019 - 10/2013
2	AngiopoietinsIBA 09/2019 - 01/2019
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2019 - 01/2019
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 04/2019 - 11/2014
2	polyethylene glycol polyethyleneimine nanogelIBA 01/2019 - 04/2013
2	Cisplatin (Platino)FDA LinkGeneric 01/2019 - 07/2010
2	TicagrelorIBA 01/2019 - 01/2017
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2018 - 04/2016
2	Phosphotransferases (Kinase)IBA 03/2018 - 04/2016

Therapy/Procedure

54	Therapeutics 12/2022 - 11/2011
20	Drug Therapy (Chemotherapy) 07/2022 - 10/2012
12	Immunotherapy 01/2022 - 09/2012
6	Photothermal Therapy 01/2022 - 11/2014
5	Lasers (Laser) 01/2017 - 11/2014
4	Intravenous Injections 12/2022 - 02/2018
3	Radiotherapy 01/2022 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 04/2019 - 11/2014
2	Precision Medicine 01/2019 - 02/2015